Cytosorbents (CTSO) Finished Goods (2023 - 2026)

Cytosorbents has reported Finished Goods for 4 years, with the latest figure at $2.7 million in Q1 2026.

• For the quarter ending Q1 2026, Finished Goods rose 45.72% year-over-year to $2.7 million; the trailing twelve-month figure through Mar 2026 stood at $2.7 million (up 45.72% YoY), and the FY2025 full-year result was $3.5 million, up 112.53% from the prior year.
• Finished Goods for Q1 2026 stood at $2.7 million, down from $3.5 million in the prior quarter.
• The five-year high for Finished Goods was $3.5 million in Q4 2025, with the low at $1.7 million in Q4 2024.
• Historically, Finished Goods has averaged $2.3 million across 4 years, with a median of $2.3 million in 2025.
• Annual changes were most pronounced in 2024 — Finished Goods declined 10.33% — and 2025, when it soared 112.53%.
• Cytosorbents' Finished Goods stood at $1.9 million in 2023, then slipped by 10.33% to $1.7 million in 2024, then surged by 112.53% to $3.5 million in 2025, then retreated by 23.58% to $2.7 million in 2026.
• The last three Finished Goods figures came in at $2.7 million (Q1 2026), $3.5 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.